Launch of new COPD guidelines

Slides:



Advertisements
Similar presentations
© Global Initiative for Chronic Obstructive Lung Disease (GOLD)
Advertisements

Assessing Risk, Negotiating for Behavior Change, Respecting Culture Standardized Patient Case DVD.
A 42 year old mother of two, Mrs Jan Jones comes into the pharmacy to fill a repeat prescription for a Ventolin Inhaler..
CHRONIC OBSTRUCTIVE PULMONARY DISEASE Major Killer disease in the world Chronic progressive disease of the lung caused by inhalation of toxic substances.
Managing Medicines Use by PBC Groups in West Hertfordshire Dr Alison Davies.
Patient Empowerment in Chronic Obstructive Pulmonary Disease (COPD) Noreen Baxter Respiratory Nurse Specialist May 2005.
World Spirometry Day, October 14, 2010 Running a mass spirometry event.
The Role of The Pharmacist
Medicines management update Catherine Butler Medicines Management Pharmacist.
Falls Prevention & Inhaler Service Update Training Claire Thomas.
South Central Respiratory Project MK Report 10 th October 2011 Nikki Hughes Community Pharmacy Lead NHS Milton keynes.
Survey of Respiratory Diagnostic Laboratories to Inform the National COPD Strategy T McCarthy,* A McGowan, ¥ M O’Connor,* on behalf of the National COPD.
PULMONARY REHABILITATION.
What China have done and will do since the GARD Launch Meeting held on March 28, 2006?
Clinical Quality Improvement: Achieving BP Control
In My Practice: Asthma in Portugal
Childhood Asthma Management Programme
W.Travis Cain, MDa, Greg Cable, PhDb, John J. Oppenheimer, MDc 
Asthma and chronic obstructive pulmonary disease (copd)
Community-Based Specialist
Medicines Management – COPD update for LPC Jyoti Saini Hema Patel
Meadowbridge Surgery Policy for prescribing of over-the-counter medicines In line with the NI Department of Health and from the 1st May 2017 this practice.
Barriers to implementing COPD guidelines for non-medical prescribers: a qualitative interview study Alison Paterson1, Anne Kinnear1, Marion Bennie2, Moira.
Sources: (1) Global Strategy for the diagnosis Management and Prevention of COPD, Global initiative for Chronic Obstructive Lung Disease (GOLD)
Copyright © 2015 by the American Osteopathic Association.
NRP 566 Education for Service-- snaptutorial.com
NRP 566 Teaching Effectively-- snaptutorial.com
The Asthma Society of Ireland
Summary and Next Steps Linda Lord – Chief Pharmacist
Treatment Strategies in Mild to Moderate COPD
The Role of Fixed-Dose Dual Bronchodilator Therapy in Treating COPD
Simple versus complex COPD: implications for health-care management
MUR and NMS Respiratory Toolkit.
Recurrent UTI in young women
COPD Management.
Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease  Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.
Grampian COPD MCN Delivering Spirometry in a Community Pharmacy setting, a rural solution? Small I (1,2), Clelland J (1,2), Robertson W (1), Freeman D.
COPD Workshop for Prescribing Lead GPs Dr Firas Watfeh, Governing Body Member and Prescribing Lead GP.
COPD Placebo Inhaler Device Kit Linda Lord,Chief Pharmacist
An Interprofessional Approach to the Patient With Chronic Airway Disease.
Best Practices in Chronic Myeloid Leukemia by Multidisciplinary Teams
A Primer on Medication Delivery Systems in COPD Management
Making best use of your medicines Please “Open UP”
From the Feds: Research, programs, and products
Personalized Disease Models on a Chip
WSCCG Woundcare Prescribing Walé Abimbola Senior Pharmacist, WSCCG
R. Graham Barr, MD, DrPH, Bartolome R. Celli, MD, Fernando J
Image of the form used by ambulance officers to triage patients with an exacerbation of chronic obstructive pulmonary disease (COPD).  GP, general practitioner;
West Suffolk CCG Update
A Primer on Medication Delivery Systems in COPD Management
Distribution of lower extremity artery disease (LEAD) Fontaine stages over the combined chronic obstructive pulmonary disease (COPD) Global Initiative.
“I wasn't phoning because the sats were low I was phoning because I couldn't breathe” The Effect of Telehealth on Patients Beliefs and Behaviours After.
The recommended approach to patients with chronic obstructive pulmonary disease (COPD) presenting with dyspnoea. The recommended approach to patients with.
Occurrence of morning symptoms
Personalized Disease Models on a Chip
Patients’ pathways to Accident and Emergency (A&E)
East Lindsey PBC Cluster
Specific therapeutic and prophylactic interventions to consider in different taxonomic groups of chronic obstructive pulmonary diseases (COPDs). Specific.
3-year survival of lung cancer patients in the general population and in those with a prior diagnosis of chronic obstructive pulmonary disease (COPD).
Schematic overview of the suggested pharmacological management of chronic obstructive pulmonary disease (COPD). Schematic overview of the suggested pharmacological.
Benefit–risk balance and its individual determinants with personalised chronic obstructive pulmonary disease (COPD) treatment choices. Benefit–risk balance.
Starting Anticoagulation with Jack
Correlation between inspiratory capacity (IC)/total lung capacity (TLC) ratio and oxygen pulse at peak exercise in chronic obstructive pulmonary disease.
Global Initiative for Chronic Obstructive Lung Disease (GOLD) classification based on symptom and risk evaluation. a) GOLD model of symptom/risk evaluation.
Distribution of NEWS in the community by service
A: Changes in percent of predicted following bronchodilator for spirometric and lung volumes variables. A: Changes in percent of predicted following bronchodilator.
Assessment of symptom burden and adherence to respiratory medications in individuals self-reporting a diagnosis of COPD within a community pharmacy setting 
Choosing inhaler therapy for patients with stable COPD based on the Global Initiative for Chronic Obstructive Lung Disease grouping. Choosing inhaler therapy.
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) ABCD scheme for classifying patients with COPD with separate appraisal of air-flow limitation.
Time taken to perform the Glittre activities of daily living (Glittre ADL) test by severity of COPD obstruction according to Global Initiative for Chronic.
Presentation transcript:

COPD Event for Practice Nurses and Community Pharmacists (02 May 2017) Walé Abimbola, Pharmacist

Launch of new COPD guidelines

Attendance

Demonstration of inhaler technique

Topics covered Global Initiative for Chronic Obstructive Lung Disease 2017 guidelines Pharmacologic management of COPD in adults COPD placebo inhaler device kit Inhalers currently prescribed in West Suffolk The role of community pharmacists in supporting the joint COPD initiative New Medicine Service Inhaler technique

Free COPD placebo inhaler device kit Guideline Placebo inhaler devices Patient information leaflets Inhaler technique videos https://www.westsuffolkccg.nhs.uk/test-page/

Questions from the event Are GPs aware of the joint COPD initiative? Do GPs support the joint COPD initiative?

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com. Inc. All rights reserved.